Clinical glaucoma management enabled by visible-light OCT
可见光 OCT 实现临床青光眼管理
基本信息
- 批准号:10487592
- 负责人:
- 金额:$ 63.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAgeAlgorithmsAnatomyAngiographyAnteriorAreaBackBiological MarkersBiological SciencesBiomedical EngineeringBlood VesselsBlood capillariesCaringCellsClinicalClinical ManagementColorDataDendritesDetectionDiagnosisDiseaseDoppler UltrasoundEyeFloorFoundationsFunctional ImagingGlaucomaGoalsHemoglobinHumanImageImaging technologyInner Plexiform LayerInterdisciplinary StudyLasersMeasurementMeasuresMechanicsMedicineMetabolicMethodologyModalityMorphologic artifactsMotionOphthalmoscopesOptical Coherence TomographyOpticsOxygenPathogenesisPathway interactionsPatientsProcessProtocols documentationResearchResolutionRetinaRetinal Ganglion CellsRodentSamplingScanningScientistStructureSynapsesSystemTechniquesTechnologyThickTimeTissuesUltrafineVariantVisible Radiationarterioleclinical careclinical imagingclinically translatablecomputerized data processingdata acquisitiondesignearly detection biomarkershealthy volunteerimage processingimaging capabilitiesimaging modalityimprovedmachine learning methodmetabolic imagingneurotoxicprogramsresearch clinical testingretinal imagingtheoriestoolultra high resolutionvenule
项目摘要
Project Summary
This collaborative technology focused project seeks to develop, characterize, and validate visible-light optical
coherence tomography (vis-OCT) as a functional tool to transform the clinical management of glaucoma. We will
address two unmet needs in clinical glaucoma diagnosis and detection of progression: (1) the ability to measure
retinal sublayer structure and (2) to accurately assess local retinal hemoglobin oxygen saturation (sO2). The
earliest structural changes in glaucoma are thought to be a retraction of retinal ganglion cell (RGC) dendrites in
the inner plexiform layer (IPL). Specifically, this would occur in the outer IPL, where RGC “off” cells synapse.
Identification of loss of synapses, either by decreased scattering or by the change in IPL sublayers’ thicknesses,
could serve as an earlier and more sensitive biomarker for glaucoma than any other. Measuring retinal sO2 and
specific arteriole-venule couplets can determine the oxygen extraction in the regions served by those vessels.
Our preliminary data indicate that regions showing damage in glaucomatous eyes have lower oxygen extraction
than similar areas in healthy eyes. Our observation suggests that such oxygen extraction abnormalities can be
measured well beyond the “floor effect” threshold noted with conventional OCT, allowing assessment of disease
beyond the time point that conventional structural OCT becomes insensitive. To achieve our long-term goal, we
will focus on new vis-OCT optical system design, imaging protocols, and data processing methodologies to
identify both metabolic and ultra-fine anatomical alternations in early glaucoma, both of which are beyond the
capabilities of existing imaging technologies.
项目摘要
这个合作技术重点项目旨在开发,表征和验证可见光光学
相干断层扫描(vis-OCT)作为一种功能性工具,以改变青光眼的临床管理。我们将
解决了临床青光眼诊断和进展检测中两个未满足的需求:(1)测量
视网膜亚层结构和(2)准确评估局部视网膜血红蛋白氧饱和度(sO2)。的
青光眼中最早的结构变化被认为是视网膜神经节细胞(RGC)树突的收缩,
内丛状层(IPL)。具体来说,这将发生在外部IPL中,在那里RGC“关闭”细胞突触。
通过散射减少或IPL亚层厚度变化识别突触丢失,
可以作为一个更早和更敏感的生物标志物青光眼比任何其他。测量视网膜sO2,
特定的小动脉-小静脉对可以决定由这些血管服务的区域中的氧提取。
我们的初步数据表明,在昏迷的眼睛显示损害的区域有较低的氧提取
比健康眼睛的相似区域更大。我们的观察表明,这种氧提取异常可能是
测量结果远远超过传统OCT的“地板效应”阈值,
超过常规结构OCT变得不敏感的时间点。为了实现长期目标,我们
将专注于新的vis-OCT光学系统设计,成像协议和数据处理方法,
确定早期青光眼的代谢和超微结构改变,这两者都超出了
现有成像技术的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel S Schuman其他文献
Lymphoma of the orbit masquerading as Tolosa-Hunt syndrome
- DOI:
10.1186/s12886-015-0037-8 - 发表时间:
2015-05-15 - 期刊:
- 影响因子:1.700
- 作者:
Tarek A Shazly;Ellen B Mitchell;Gabrielle R Bonhomme;Joel S Schuman - 通讯作者:
Joel S Schuman
Joel S Schuman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel S Schuman', 18)}}的其他基金
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1
针对结构和功能的新型青光眼诊断 - 更新 - 1
- 批准号:
10866656 - 财政年份:2023
- 资助金额:
$ 63.19万 - 项目类别:
Clinical glaucoma management enabled by visible-light OCT
可见光 OCT 实现临床青光眼管理
- 批准号:
10696088 - 财政年份:2021
- 资助金额:
$ 63.19万 - 项目类别:
Clinical glaucoma management enabled by visible-light OCT
可见光 OCT 实现临床青光眼管理
- 批准号:
10279742 - 财政年份:2021
- 资助金额:
$ 63.19万 - 项目类别:
Novel Glaucoma Diagnostics for Structure and Function
新型青光眼结构和功能诊断
- 批准号:
9542334 - 财政年份:2016
- 资助金额:
$ 63.19万 - 项目类别:
Novel Glaucoma Diagnostics for Structure and Function
新型青光眼结构和功能诊断
- 批准号:
9350830 - 财政年份:2016
- 资助金额:
$ 63.19万 - 项目类别:
Novel Glaucoma Diagnostics for Structure and Function
新型青光眼结构和功能诊断
- 批准号:
7487755 - 财政年份:2005
- 资助金额:
$ 63.19万 - 项目类别:
Novel Glaucoma Diagnostics for Structure and Function
新型青光眼结构和功能诊断
- 批准号:
7674649 - 财政年份:2005
- 资助金额:
$ 63.19万 - 项目类别:
Novel Glaucoma Diagnostics for Structure and Function
新型青光眼结构和功能诊断
- 批准号:
6983251 - 财政年份:2005
- 资助金额:
$ 63.19万 - 项目类别:
Novel Glaucoma Diagnostics for Structure and Function
新型青光眼结构和功能诊断
- 批准号:
7124631 - 财政年份:2005
- 资助金额:
$ 63.19万 - 项目类别:
Novel Glaucoma Diagnostics for Structure and Function
新型青光眼结构和功能诊断
- 批准号:
7273552 - 财政年份:2005
- 资助金额:
$ 63.19万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 63.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 63.19万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 63.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.19万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 63.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.19万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 63.19万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 63.19万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 63.19万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 63.19万 - 项目类别:
Standard Grant